Investigation of this hypothesis in the future may be fundamental to understanding the exact molecular mechanism by which Nrf2 signaling is compromised in STHdhQ111/Q111 cells and to provide insights into development of therapeutic strategies of HD. This evidence concerns the gene NFE2L2 and Huntington disease.